Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.07 0.05
mRNA erismodegib CTRPv2 pan-cancer AAC -0.073 0.05
mRNA Imatinib GDSC1000 pan-cancer AAC 0.1 0.05
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.067 0.05
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.069 0.05
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.063 0.06
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.065 0.06
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.06
Download CSV